{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T01:36:36Z","timestamp":1768440996510,"version":"3.49.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T00:00:00Z","timestamp":1558915200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T00:00:00Z","timestamp":1558915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s11239-019-01884-z","type":"journal-article","created":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T12:03:56Z","timestamp":1558958636000},"page":"454-458","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Concurrent presentation of a hemorrhagic pericardial effusion and venous thromboembolism in malignancy: a systematic review of case studies"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3890-3929","authenticated-orcid":false,"given":"Krishna","family":"Pabba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristhiam M.","family":"Rojas-Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,27]]},"reference":[{"issue":"6","key":"1884_CR1","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/j.1445-5994.2012.02808.x","volume":"42","author":"N Wickham","year":"2012","unstructured":"Wickham N, Gallus AS, Walters BN, Wilson A, Committee NVPGA (2012) Prevention of venous thromboembolism in patients admitted to Australian hospitals: summary of National Health and Medical Research Council clinical practice guideline. Intern Med J 42(6):698\u2013708. \n                    https:\/\/doi.org\/10.1111\/j.1445-5994.2012.02808.x","journal-title":"Intern Med J"},{"issue":"2","key":"1884_CR2","first-page":"129","volume":"18","author":"J Belohlavek","year":"2013","unstructured":"Belohlavek J, Dytrych V, Linhart A (2013) Pulmonary embolism, part I: epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism. Exp Clin Cardiol 18(2):129\u2013138","journal-title":"Exp Clin Cardiol"},{"issue":"3","key":"1884_CR3","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/j.1538-7836.2007.02374.x","volume":"5","author":"AA Khorana","year":"2007","unstructured":"Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH (2007) Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost 5(3):632\u2013634. \n                    https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02374.x","journal-title":"J Thromb Haemost"},{"issue":"1","key":"1884_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/jth.12070","volume":"11","author":"D Farge","year":"2013","unstructured":"Farge D, Debourdeau P, Beckers M, Baglin C, Bauersachs RM, Brenner B, Brilhante D, Falanga A, Gerotzafias GT, Haim N, Kakkar AK, Khorana AA, Lecumberri R, Mandala M, Marty M, Monreal M, Mousa SA, Noble S, Pabinger I, Prandoni P, Prins MH, Qari MH, Streiff MB, Syrigos K, Bounameaux H, Buller HR (2013) International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. J Thromb Haemost 11(1):56\u201370. \n                    https:\/\/doi.org\/10.1111\/jth.12070","journal-title":"J Thromb Haemost"},{"issue":"2","key":"1884_CR5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","volume":"149","author":"C Kearon","year":"2016","unstructured":"Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, Huisman M, King CS, Morris TA, Sood N, Stevens SM, Vintch JRE, Wells P, Woller SC, Moores L (2016) Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest 149(2):315\u2013352","journal-title":"Chest"},{"issue":"17","key":"1884_CR6","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1200\/JCO.2013.49.1118","volume":"31","author":"GH Lyman","year":"2013","unstructured":"Lyman GH, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP, Clarke JM, Flowers CR, Francis CW, Gates LE, Kakkar AK, Key NS, Levine MN, Liebman HA, Tempero MA, Wong SL, Prestrud AA, Falanga A, American Society of Clinical Oncology Clinical P (2013) Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31(17):2189\u20132204. \n                    https:\/\/doi.org\/10.1200\/jco.2013.49.1118","journal-title":"J Clin Oncol"},{"key":"1884_CR7","doi-asserted-by":"publisher","first-page":"vi85","DOI":"10.1093\/annonc\/mdr392","volume":"22","author":"M Mandala","year":"2011","unstructured":"Mandala M, Falanga A, Roila F, Group EGW (2011) Management of venous thromboembolism (VTE) in cancer patients: ESMO clinical practice guidelines. Ann Oncol 22:vi85\u2013vi92. \n                    https:\/\/doi.org\/10.1093\/annonc\/mdr392","journal-title":"Ann Oncol"},{"issue":"9","key":"1884_CR8","doi-asserted-by":"publisher","first-page":"270","DOI":"10.4330\/wjc.v2.i9.270","volume":"2","author":"C Lestuzzi","year":"2010","unstructured":"Lestuzzi C (2010) Neoplastic pericardial disease: old and current strategies for diagnosis and management. World J Cardiol 2(9):270\u2013279. \n                    https:\/\/doi.org\/10.4330\/wjc.v2.i9.270","journal-title":"World J Cardiol"},{"issue":"4","key":"1884_CR9","first-page":"281","volume":"5","author":"M Petrofsky","year":"2014","unstructured":"Petrofsky M (2014) Management of malignant pericardial effusion. J Adv Pract Oncol 5(4):281\u2013289","journal-title":"J Adv Pract Oncol"},{"key":"1884_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-202285","author":"C Thomas","year":"2014","unstructured":"Thomas C, Lane K, Cecconi M (2014) Pulmonary embolism with haemorrhagic pericardial effusion and tamponade: a clinical dilemma. BMJ Case Rep. \n                    https:\/\/doi.org\/10.1136\/bcr-2013-202285","journal-title":"BMJ Case Rep"},{"issue":"6","key":"1884_CR11","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/clc.4960240614","volume":"24","author":"UC Jairath","year":"2001","unstructured":"Jairath UC, Benotti JR, Spodick DH (2001) Cardiac tamponade masking pulmonary embolism. Clin Cardiol 24(6):485\u2013486","journal-title":"Clin Cardiol"},{"key":"1884_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.11604\/pamj.2014.18.15.2469","volume":"18","author":"S Akhbour","year":"2014","unstructured":"Akhbour S, Khennine BA, Oukerraj L, Zarzur J, Cherti M (2014) Pericardial tamponade and coexisting pulmonary embolism as first manifestation of non-advanced lung adenocarcinoma. Pan Afr Med J 18:15. \n                    https:\/\/doi.org\/10.11604\/pamj.2014.18.15.2469","journal-title":"Pan Afr Med J"},{"issue":"2","key":"1884_CR13","first-page":"e33","volume":"15","author":"DH Hsi","year":"2010","unstructured":"Hsi DH, Krishnamurthy M, Ryan GF, Luo P, Woodlock TJ (2010) Successful management of hemopericardium and cardiac tamponade secondary to occult malignancy and anticoagulation. Exp Clin Cardiol 15(2):e33\u2013e35","journal-title":"Exp Clin Cardiol"},{"issue":"8","key":"1884_CR14","first-page":"2126","volume":"3","author":"S Kandasamy","year":"2017","unstructured":"Kandasamy S, Tadi MEF, Rudrapogu JS, Biju G, Boddikura C, Naralasetty AK (2017) Pericardial tamponade masking associated pulmonary thrombo embolism in a case of adeno carcinoma of lung. Int J Res Med Sci 3(8):2126\u20132128","journal-title":"Int J Res Med Sci"},{"issue":"6","key":"1884_CR15","first-page":"367","volume":"14","author":"L Barski","year":"2012","unstructured":"Barski L, Shalev L, Zektser M, Malada-Mazri H, Abramov D, Rafaely Y (2012) Large hemorrhagic pericardial effusion. Israel Med Assoc J 14(6):367\u2013371","journal-title":"Israel Med Assoc J"},{"issue":"10","key":"1884_CR16","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.annfar.2003.09.016","volume":"22","author":"V Nguyen Ba","year":"2003","unstructured":"Nguyen Ba V, Debien B, Villevieille T, Quiniou G, Pollet L, Lenoir B, Pats B (2003) Pulmonary embolism to the rescue in cardiac tamponade. Ann Fr Anesth Reanim 22(10):896\u2013899","journal-title":"Ann Fr Anesth Reanim"},{"issue":"22","key":"1884_CR17","doi-asserted-by":"publisher","first-page":"5211","DOI":"10.1200\/JCO.2005.00.745","volume":"23","author":"HL Gornik","year":"2005","unstructured":"Gornik HL, Gerhard-Herman M, Beckman JA (2005) Abnormal cytology predicts poor prognosis in cancer patients with pericardial effusion. J Clin Oncol 23(22):5211\u20135216. \n                    https:\/\/doi.org\/10.1200\/JCO.2005.00.745","journal-title":"J Clin Oncol"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-019-01884-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-019-01884-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-019-01884-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,25]],"date-time":"2020-05-25T23:10:08Z","timestamp":1590448208000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-019-01884-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,27]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["1884"],"URL":"https:\/\/doi.org\/10.1007\/s11239-019-01884-z","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,27]]},"assertion":[{"value":"27 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Rojas-Hernandez has received funding from Daichii-Sankyo clinical research with oral anticoagulants in cancer associated venous thrombosis. Dr Pabba has no competing interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}